refundacja
Ozempic breaks records in reimbursement. After five months, it already has more than half of the result for the entire 2025. There are two more GLP-1 analogues in the reimbursement system. Only from January to May 2026, the National Health Fund spent approximately PLN 264.5 million on reimbursement of Ozempic, Trulicity and Suliqui.
Peak volume
500+
First seen
2026-08-14
Last seen
2026-08-18
Days trending
2 / 5
Countries
1
Trending timeline
Latest related news (2026-08-18)
-
-
Tyle NFZ dopłaca za słynne leki na odchudzanie — Rzeczpospolita
-